CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM

SIMPLE SUMMARY: In the present work, we describe (for the first time) the use of the transmembrane protein, CD44v6, to detect CTCs from blood samples of several patients with colorectal or breast cancer. We used CD44v6 antibodies to demonstrate that live CTCs can be specifically purified from CRC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Belthier, Guillaume, Homayed, Zeinab, Grillet, Fanny, Duperray, Christophe, Vendrell, Julie, Krol, Ilona, Bravo, Sophie, Boyer, Jean-Christophe, Villeronce, Olivia, Vitre-Boubaker, Jihane, Heaug-Wane, Diana, Macari-Fine, Françoise, Smith, Jai, Merlot, Matthieu, Lossaint, Gérald, Mazard, Thibault, Portales, Fabienne, Solassol, Jérôme, Ychou, Marc, Aceto, Nicola, Mamessier, Emilie, Bertucci, François, Pascussi, Jean Marc, Samalin, Emmanuelle, Hollande, Frédéric, Pannequin, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508506/
https://www.ncbi.nlm.nih.gov/pubmed/34638450
http://dx.doi.org/10.3390/cancers13194966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508506/
https://www.ncbi.nlm.nih.gov/pubmed/34638450
http://dx.doi.org/10.3390/cancers13194966

Ejemplares similares